Convert your Pasireotide dose
Vial
Result
Converted amount0.3 mg
Dose mass300 mcg
Concentration2,500 mcg/mL
Draw volume0.12 mL
U-100 syringe12 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| Cushing's disease | subcutaneous | 300–900 mcg | twice daily |
| acromegaly (LAR formulation) | intramuscular | 40–60 mg | every 4 weeks |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 300 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 0.15 mL | 15 units | 7 |
| 2 mg | 2 mL | 0.3 mL | 30 units | 7 |
| 2 mg | 3 mL | 0.45 mL | 45 units | 7 |
| 5 mg | 1 mL | 0.06 mL | 6 units | 17 |
| 5 mg | 2 mL | 0.12 mL | 12 units | 17 |
| 5 mg | 3 mL | 0.18 mL | 18 units | 17 |
| 10 mg | 1 mL | 0.03 mL | 3 units | 33 |
| 10 mg | 2 mL | 0.06 mL | 6 units | 33 |
| 10 mg | 3 mL | 0.09 mL | 9 units | 33 |
Calculated for the low end of the reported Cushing's disease range. Change the dose in the calculator above for any other amount.
Pasireotide at a glance
~12 hours (SC); ~23 days (LAR)
Half-life
1,047.23 Da
Molecular weight
subcutaneous, intramuscular
Routes
prescription
Legal status